Table 1.

Baseline characteristics of combined sample & comparisons between Study 1 and Study 2

	Combined Sample		Comparison between study groups
			Study 1 (N = 322)		Study 2 (N = 207)
	N	Mean (SD) or No. (%)	N	Mean (SD) or No. (%)	N	Mean (SD) or No. (%)	p *
Demographic variables
Age	529	64.7 (10.7)	322	65.0 (11.2)	207	64.3 (9.9)	.453
Gender (male)	529	296 (56%)	322	187 (58.1%)	207	109 (52.7%)	.221
Rural residence	529	306 (57.8%)	322	181 (56.2%)	207	125 (60.4%)	.343
College graduate	482	166 (34.4%)	275	81 (29.5%)	207	85 (41.1%)	.008
Married	526	356 (67.7%)	319	221 (69.3%)	207	135 (65.2%)	.331
Employed	525	112 (21.3%)	318	63 (19.8%)	207	49 (23.7%)	.291
White	485	475 (97.9%)	279	275 (98.6%)	206	200 (97.1%)	.257
Cancer site
Lung (NSCLC)	529	205 (38.8%)	322	117 (36.3%)	207	88 (42.5%)	.155
Gastrointestinal	529	183 (34.6%)	322	133 (41.3%)	207	50 (24.2%)	.000
Genitourinary	529	55 (10.4%)	322	39 (12.1%)	207	16 (7.7%)	.107
Breast	529	56 (10.6%)	322	33 (10.2%)	207	23 (11.1%)	.753
Hematological	529	10 (1.9%)	322	0 (0%)	207	10 (4.8%)	.000
Other cancer	529	20 (3.8%)	322	0 (0%)	207	20 (9.7%)	.000
x Days in hospital	528	2.79 (5.2)	322	2.95 (5.2)	206	2.54 (5.2)	.381
Days in ICU	404	.18 (.92)	322	.03 (.25)	82	.74 (1.9)	.001
ED visits	529	.43 (.84)	322	.34 (.78)	207	.57 (.90)	.003
Advanced directives	527	238 (45.2%)	322	149 (46.3%)	205	89 (43.4%)	.520
Do not resuscitate	515	43 (8.3%)	322	23 (7.1%)	193	20 (10.4%)	.201
Chemotherapy	529	427 (80.7%)	322	271 (84.2%)	207	156 (75.4%)	.012
Radiation	529	81 (15.3%)	322	41 (12.7%)	207	40 (19.3%)	.040
Hope
Baseline HOPE	465	8.1 (2.7)	264	8.1 (2.6)	201	8.1 (2.8)	.958

Abbreviations: SD = Standard Deviation; % = Percent of total patients; ICU = Intensive Care Unit; ED = Emergency Medicine Department.

^*Independent samples t-tests were used for continuous variables (Age, Days in hospital, Days in ICU, ER visits, and Baseline HOPE); Chi-Squared analyses were used for categorical variables.